Please login to the form below

Not currently logged in
Email:
Password:

Five companies breach ABPI code

Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline named by PMCPA
ABPI code of practice

Five pharma companies have breached the Code of Practice of the Association of British Pharmaceutical Industries (ABPI)

Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline (GSK) were named by the PMCPA – the Code's administrator - in medical, pharmaceutical and nursing press advertisements for Code breaches.

All five breached clause 2, which constitutes bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Lundbeck, A Menarini and Bayer breached the Code by each sponsoring a speaker or speakers and paying for exhibition space at a meeting not primarily educational in purpose, and by the impression given by their involvement. 

In addition to clause 2, this breached clause 9.1 (failing to maintain high standards) and clause 19.1 (failing to meet the requirements for meetings).

HRA Pharma UK breached six clauses as a result of emails sent by a representative to a health professional regarding the provision of an emergency contraception service and the use of ellaOne (ulipristal acetate).

The breached clauses were 2, 7.2 (making a misleading claim), 7.10 (making an exaggerated claim), 8.2 (disparaging a service provision), 9.1 (failing to maintain high standards) and 15.2 (failing to maintain a high standard of ethical conduct).

GSK breached clauses 2, 9.1 and 14.3 (failing to certify joint working materials before use) after making a voluntary admission that it had not formally certified materials relating to a joint working project with the NHS until some months after the project had started.

The advertisements will appear in the BMJ Clinical Research and the Pharmaceutical Journal on March 1, 2014, the Nursing Standard on March 5, 2014, and the BMJ General Practice on March 8, 2014.

4th March 2014

From: Marketing, Regulatory, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics